Prevention of diabetes in NOD mice by repeated exposures to a contact allergen inducing a sub-clinical dermatitis

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Engkilde, Kaare ^a   Buschard, Karsten ^b   Hansen, Axel Kornerup ^c   Menné, Torkil ^a   Johansen, Jeanne Duus ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CONTACT ALLERGEN; PHENYLENEDIAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; SENSITIZATION; SKIN ALLERGY;

ALLERGENS; ANIMALS; DERMATITIS, ALLERGIC CONTACT; DIABETES MELLITUS, EXPERIMENTAL; LYMPH NODES; MICE; MICE, INBRED NOD; NATURAL KILLER T-CELLS; PHENYLENEDIAMINES;

MUS;

EID: 77956552339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010591     Document Type: Article

References (35)

1. EURODIAB ACE Study Group (2000) Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355: 873-876.
2. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.
3. Cardell SL (2006) The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin Exp Immunol 143: 194-202.
4. Olesen AB, Juul S, Birkebaek N, Thestrup-Pedersen K (2001) Association between atopic dermatitis and insulin-dependent diabetes mellitus: a casecontrol study. Lancet 357: 1749-1752.
5. Cardwell CR, Shields MD, Carson DJ, Patterson CC (2003) A meta-analysis of the association between childhood type 1 diabetes and atopic disease. Diabetes Care 26: 2568-2574.
6. Tirosh A, Mandel D, Mimouni FB, Zimlichman E, Shochat T, et al. (2006) Autoimmune diseases in asthma. Ann Intern Med 144: 877-883.
7. Cavani A, De PO, Girolomoni G (2007) New aspects of the molecular basis of contact allergy. Curr Opin Allergy Clin Immunol 7: 404-408.
8. Basketter DA (2008) Skin sensitization: strategies for the assessment and management of risk. Br J Dermatol 159: 267-273.
9. Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183: 1001-1012.
10. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, et al. (1999) Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 189: 779-786.
11. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF (2004) The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 14: 131-138.
12. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, et al. (2006) CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 126: 815-820.
13. Engkilde K, Menné T, Johansen JD (2006) Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study. Diabetologia 49: 644-647.
14. Poulton LD, Baxter AG (2001) Clinical application of NKT cell assays to the prediction of type 1 diabetes. Diabetes Metab Res Rev 17: 429-435.
15. Nieuwenhuis EE, Gillessen S, Scheper RJ, Exley MA, Taniguchi M, et al. (2005) CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp Dermatol 14: 250-258.
16. Campos RA, Szczepanik M, Lisbonne M, Itakura A, Leite-De-Moraes M, et al. (2006) Invariant NKT Cells Rapidly Activated via Immunization with Diverse Contact Antigens Collaborate In Vitro with B-1 Cells to Initiate Contact Sensitivity. J Immunol 177: 3686-3694.
17. Gober MD, Fishelevich R, Zhao Y, Unutmaz D, Gaspari AA (2008) Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol 128: 1460-1469.
18. Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, et al. (2001) ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. Regul Toxicol Pharmacol 34: 258-273.
19. Warbrick EV, Dearman RJ, Lea LJ, Basketter DA, Kimber I (1999) Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations. J Appl Toxicol 19: 255-260.
20. Basketter DA, Gerberick F, Kimber I (2007) The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermatitis 57: 70-75.
21. Harada D, Takada C, Tsukumo Y, Takaba K, Manabe H (2005) Analyses of a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application. J Dermatol Sci 37: 159-167.
22. Martin SF, Jakob T (2008) From innate to adaptive immune responses in contact hypersensitivity. Current Opinion in Allergy and Clinical Immunology 8: 289-293.
23. Nakano Y, Nakano K (1981) Induction of Contact Sensitivity and Antigenic-Competition by the Intravenous Administration of Contact Sensitizers. Immunology 42: 111-118.
24. Furue M, Tamaki K (1985) Induction and Suppression of Contact Sensitivity to Fluorescein Isothiocyanate (Fitc). Journal of Investigative Dermatology 85: 139-142.
25. Seidel-Guyenot W, Perschon S, Dechant N, Alt R, Knop J, et al. (2006) Low zone tolerance induced by systemic application of allergens inhibits T(C)1-mediated skin inflammation. Journal of Allergy and Clinical Immunology 117: 1170-1177.
26. WBonefeld CM, Larsen JM, Dabelsteen S, Geisler C, White IR, et al. (2009) Consumer available permanent hair dye products cause major allergic immune activation in an animal model. Br J Dermatol.
27. Edwards EK, Edwards EK (1984) Contact Urticaria and Allergic Contact- Dermatitis Caused by Paraphenylenediamine. Cutis 34: 87-88.
28. White JM, Basketter DA, Pease CK, Sanders DA, McFadden JP (2007) Intermittent exposure to low-concentration paraphenylenediamine can be equivalent to single, higher-dose exposure. Contact Dermatitis 56: 262-265.
29. Mitjans M, Marinovich M, Lucchi L, Galli CL, Corsini E (2007) Role of p38 MAPK in chemical allergen-induced selective production of IL-8 in naive THP-1 cells. Toxicology Letters 172: S86-S87.
30. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, et al. (1996) Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 26: 2989-2998.
31. Wu L, Van Kaer L (2007) Role of NKT cells in the digestive system. II. NKT cells and diabetes. Am J Physiol Gastrointest Liver Physiol 293: G919-G922.
32. Kaufman A, Herold KC (2009) Anti-CD3 mAbs for treatment of type 1 diabetes. Diabetes Metab Res Rev.
33. Sadelain MW, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589.
34. Gazda LS, Baxter AG, Lafferty KJ (1996) Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol Cell Biol 74: 401-407.
35. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJL, Hayakawa Y, et al. (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. Journal of Immunology 171: 4020-4027.